- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x PHQ- ASP- GLU- VAL- MY1: AZA-PEPTIDE EXPOXIDE(Non-covalent)
PHQ-ASP-GLU-VAL-MY1.1: 27 residues within 4Å:- Chain A: M.33, R.36, S.37, S.92, H.93, G.94, E.95, F.100, Q.133, A.134, C.135, G.137, T.138
- Chain B: Y.30, S.31, W.32, R.33, N.34, S.35, W.40, E.74, S.75, F.76, F.78, F.82
- Chain D: D.5
- Chain E: E.95
34 PLIP interactions:18 interactions with chain B, 15 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: B:Y.30, B:W.32, B:W.32, B:F.76, B:F.78, B:F.82, A:M.33, A:H.93, A:E.95, A:E.95, A:T.138
- Hydrogen bonds: B:S.31, B:R.33, B:R.33, B:R.33, B:N.34, B:S.35, B:F.76, B:F.76, B:F.76, A:S.37, A:S.37, A:H.93, A:G.94, A:Q.133, A:C.135, D:D.5
- Water bridges: B:K.36
- Salt bridges: B:R.33, B:R.33, A:R.36, A:H.93
- pi-Stacking: A:H.93, A:F.100
PHQ-ASP-GLU-VAL-MY1.2: 27 residues within 4Å:- Chain B: D.5
- Chain C: M.33, R.36, S.37, S.92, H.93, G.94, E.95, F.100, Q.133, A.134, C.135, G.137, T.138
- Chain D: Y.30, S.31, W.32, R.33, N.34, S.35, W.40, E.74, S.75, F.76, F.78, F.82
- Chain G: E.95
33 PLIP interactions:15 interactions with chain C, 18 interactions with chain D- Hydrophobic interactions: C:M.33, C:H.93, C:E.95, C:E.95, C:T.138, D:Y.30, D:W.32, D:W.32, D:F.76, D:F.78, D:F.82
- Hydrogen bonds: C:S.37, C:S.37, C:H.93, C:G.94, C:Q.133, C:C.135, D:S.31, D:R.33, D:R.33, D:R.33, D:R.33, D:N.34, D:S.35, D:F.76, D:F.76
- Salt bridges: C:R.36, C:H.93, D:R.33, D:R.33
- pi-Stacking: C:H.93, C:F.100
- Water bridges: D:K.36
PHQ-ASP-GLU-VAL-MY1.3: 27 residues within 4Å:- Chain A: E.95
- Chain E: M.33, R.36, S.37, S.92, H.93, G.94, E.95, F.100, Q.133, A.134, C.135, G.137, T.138
- Chain F: Y.30, S.31, W.32, R.33, N.34, S.35, W.40, E.74, S.75, F.76, F.78, F.82
- Chain H: D.5
34 PLIP interactions:15 interactions with chain E, 18 interactions with chain F, 1 interactions with chain H- Hydrophobic interactions: E:M.33, E:H.93, E:E.95, E:E.95, E:T.138, F:Y.30, F:W.32, F:W.32, F:F.76, F:F.78, F:F.82
- Hydrogen bonds: E:S.37, E:S.37, E:H.93, E:G.94, E:Q.133, E:C.135, F:S.31, F:R.33, F:R.33, F:R.33, F:N.34, F:S.35, F:F.76, F:F.76, F:F.76, H:D.5
- Salt bridges: E:R.36, E:H.93, F:R.33, F:R.33
- pi-Stacking: E:H.93, E:F.100
- Water bridges: F:K.36
PHQ-ASP-GLU-VAL-MY1.4: 27 residues within 4Å:- Chain C: E.95
- Chain F: D.5
- Chain G: M.33, R.36, S.37, S.92, H.93, G.94, E.95, F.100, Q.133, A.134, C.135, G.137, T.138
- Chain H: Y.30, S.31, W.32, R.33, N.34, S.35, W.40, E.74, S.75, F.76, F.78, F.82
33 PLIP interactions:18 interactions with chain H, 15 interactions with chain G- Hydrophobic interactions: H:Y.30, H:W.32, H:W.32, H:F.76, H:F.78, H:F.82, G:M.33, G:H.93, G:E.95, G:E.95, G:T.138
- Hydrogen bonds: H:S.31, H:R.33, H:R.33, H:R.33, H:R.33, H:N.34, H:S.35, H:F.76, H:F.76, G:S.37, G:S.37, G:H.93, G:G.94, G:Q.133, G:C.135
- Water bridges: H:K.36
- Salt bridges: H:R.33, H:R.33, G:R.36, G:H.93
- pi-Stacking: G:H.93, G:F.100
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ganesan, R. et al., Exploring the S4 and S1 Prime Subsite Specificities in Caspase-3 with Aza-Peptide Epoxide Inhibitors. Biochemistry (2006)
- Release Date
- 2007-03-20
- Peptides
- CASPASE-3 SUBUNIT P17: ACEG
CASPASE-3 SUBUNIT P12: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x PHQ- ASP- GLU- VAL- MY1: AZA-PEPTIDE EXPOXIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ganesan, R. et al., Exploring the S4 and S1 Prime Subsite Specificities in Caspase-3 with Aza-Peptide Epoxide Inhibitors. Biochemistry (2006)
- Release Date
- 2007-03-20
- Peptides
- CASPASE-3 SUBUNIT P17: ACEG
CASPASE-3 SUBUNIT P12: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B